Araceli Biosciences

United States Founded: 2020 • Age: 6 yrs
Scientific tools for tissue and cell-based biomarker discovery are developed.

About Araceli Biosciences

Araceli Biosciences is a Healthcare company based in United States founded in 2020. Scientific tools for tissue and cell-based biomarker discovery are developed. Araceli Biosciences has raised $21 million across 5 funding rounds from investors including Bill Cortelyou. Araceli Biosciences offers products and services including Endeavor Automation and Clairvoyance Software. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery. Its competitors include Lodestone Biomedical, BioAmp Diagnostics and ThinkSense; 1 of its 3 listed competitors has raised funding.

Company details

Developer of scientific tools for tissue and cell-based biomarker discovery drug development. The company is involved in the development of an instrumentation system to improve precision analysis of products by using artificial intelligence. It has developed an endeavor molecular imaging device that helps to identify cell counting, cell cycle, cell differentiation, cell morphology, cell viability, and many more.

  • Headquarters United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website aracelibio.com
  • Social LinkedIn X YouTube
Key Metrics
  • Total Equity Funding
    $21M (USD)

    in 5 rounds

  • Latest Funding Round
    $2.53M (USD), Seed

    Oct 2026

Products & Services of Araceli Biosciences

Araceli Biosciences offers a comprehensive portfolio of products and services, including Endeavor Automation and Clairvoyance Software.

Endeavor Automation
Automation Hardware

Hardware for rapid plate scanning in drug discovery processes

Clairvoyance Software
AI Software

Software for advanced image analysis in therapeutic research

Apps and channels of Araceli Biosciences

its YouTube channel Araceli Biosciences has 20 subscribers and 30 videos.

Araceli Biosciences
YouTube 20 subscribers 30 videos Science & Technology
Open channel

Videos from Araceli Biosciences

The most watched videos on Araceli Biosciences's YouTube channel, Araceli Biosciences (20 subscribers). Click a video to play it here.

Science in Real Time (ScienceIRT) Episode 1 – Opening the Lab Notebook
48 views
ScienceIRT Episode 2 – Unlocking the Power of GDPx3 with Ginkgo Datapoints (Spotlight)
44 views
ScienceIRT Episode 3 - Predictive Biology: Organoids, AI, and the Next Era of Research (BioScopes)
35 views
ScienceIRT Episode 5 - CellCLIP: When Cell Painting Meets AI and Natural Language (Molecule Talk)
31 views

More on Araceli Biosciences.

Funding Insights of Araceli Biosciences

Araceli Biosciences has successfully raised a total of $21M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $2.53 million completed in October 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $21M
  • Total Rounds 5
  • Last Round Seed β€” $2.53M
  • First Round $2.23M

    (Apr 2023)

  • Investors Count 1

All 5 funding rounds of Araceli Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2026$2.53MSeries A––
–
Oct 2026$2.53MSeed––
–
Apr 2025$11.2MSeed–Bill Cortelyou
–
Dec 2024$2.53MSeed––
–
Apr 2023$2.23MSeed––
–
Valuation history

1 investors in total: 0 institutional and 1 angel.

Investors in Araceli Biosciences

Araceli Biosciences has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Bill Cortelyou.

All
Angel
InvestorDescriptionFounded YearDomainLocation

Bill Cortelyou

unknown_84a76b4daff54b22b
Premium access

Investor details for Araceli Biosciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Araceli Biosciences

18 people are tracked at Araceli Biosciences (5 in leadership, 13 in team).

NameRoleGroup
Bill Cortelyou
Chief Executive OfficerLeadership
Jonathan Day
Vice President WW Sales And SupportLeadership
Shawn MacDonald
CFOLeadership
Scott Igl
Vice President of EngineeringLeadership
Don Weldon
VP Of MarketingLeadership
Kevin Ferguson
Principal Systems EngineerTeam
Timm Derrickson
Data Scientist–Software EngineerTeam
Mike Bitsch
Principal Design EngineerTeam
Swathi Shanbhag
Software EngineerTeam
Sam Gerendasy
Software Engineering ManagerTeam
Gery Gross
Senior Software EngineerTeam
Dan Ngo
Software EngineerTeam
Amanda Clement
Manager, Global Field Applications, Service And SupportTeam
Matt Addington
Manufacturing EngineerTeam
Matt Boisvert
Application ScientistTeam
Kristin Halfpenny
Business Development ManagerTeam
Jasmine Silver
Senior Graphic DesignerTeam
Theresa Thompson
Applications Scientist & EngineerTeam
Premium access

Complete people profiles for Araceli Biosciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Araceli Biosciences

3 dated milestones of Araceli Biosciences across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Araceli Biosciences is founded.
  2. Funding First funding round of $2.2M.
  3. Funding Latest funding round, Seed, of $2.5M.

Competitors of Araceli Biosciences

Araceli Biosciences has 3 listed competitors in our database, 1 of them funded. They include Lodestone Biomedical, BioAmp Diagnostics and ThinkSense.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lodestonebiomedical.com2015Hanover, United States$1.19M
Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology
bioampdx.com2017Berkeley, United States
Developers of diagnostic tests that help to treat patient with a specific antibiotic
thinksense.com2004Mclean, United States
Develops sensors for behavioral health data collection and analysis in trials.
Premium access

Detailed competitors of Araceli Biosciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Araceli Biosciences

The website of Araceli Biosciences (aracelibio.com) receives about 4.4K visits a month.

  • Monthly visits
    4.4K

    ▼ 11.4% vs previous month

Similar websites

Websites whose visitors overlap most with Araceli Biosciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
tricolbiomedical.com
100%
1.4K#10,764,834View details
sediabio.com
93%
2K#6,996,278View details
otradi.org
92%
#8,709,976View details
lumencor.com
91%
5.5K#3,662,927View details

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Araceli Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Araceli Biosciences

Premium access

Complete news archive for Araceli Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Araceli Biosciences

Araceli Biosciences was founded in 2020 and raised its 1st funding round 3 years after it was founded.

Araceli Biosciences is headquartered in United States.

Araceli Biosciences is a funded company, having raised a total of $21M across 5 funding rounds to date. The company's 1st funding round was a Seed of $2.23M, raised on Apr 2023.

Developer of scientific tools for tissue and cell-based biomarker discovery drug development. The company is involved in the development of an instrumentation system to improve precision analysis of products by using artificial intelligence. It has developed an endeavor molecular imaging device that helps to identify cell counting, cell cycle, cell differentiation, cell morphology, cell viability, and many more.

Araceli Biosciences's top competitors include Lodestone Biomedical, BioAmp Diagnostics and ThinkSense.

Araceli Biosciences offers Endeavor Automation and Clairvoyance Software.

Araceli Biosciences has 1 investor. Key investors include Bill Cortelyou.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available